Concepedia
Statistics
Publications
36
Citations
3.5K
H-Index
28
Active since
1966
Affiliations
Dynavax Technologies (United States)(Current)
University of California, San Francisco
Itron (United States)
University of Michigan
Chiron (Norway)
Gary Ott is an author at Dynavax Technologies (United States) specializing in medicine, immunology, and vaccination.
Top concepts
MedicineImmunologyVaccinationImmunotherapyVaccine DevelopmentVirologyBiochemistryCell BiologyCross-protectionBioanalysis
Publications per year
1966–2016
Cationic microparticles: A potent delivery system for DNA vaccines
Manmohan Singh, Maylene Briones, Gary Ott et al. · Proceedings of the National Academy of Sciences · 2000 · 492 citations
Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation
Cristiana Guiducci, Gary Ott, Jean H. Chan et al. · The Journal of Experimental Medicine · 2006 · 378 citations · Full text
Adaptive Immune System, Innate Immune System, Immunology +18
Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice
Marc Dupuis, Kimberly Denis-Mize, Carolyn Woo et al. · The Journal of Immunology · 2000 · 328 citations · Full text
Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response
Baidong Hou, Philippe Saudan, Gary Ott et al. · Immunity · 2011 · 232 citations · Full text
Autoimmune Disease, Myd88 Signaling, Immunology +12
Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection
Marc Dupuis, Thomas J. Murphy, Deborah Higgins et al. · Cellular Immunology · 1998 · 182 citations
Vaccination, Cross-protection, Vaccine Development +6
1–5 of 36